ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 250 filers reported holding ALKERMES PLC in Q4 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,363,700 | -5.4% | 370,000 | +5.7% | 1.12% | -3.3% |
Q2 2023 | $10,955,000 | +191.7% | 350,000 | +159.3% | 1.16% | +180.3% |
Q1 2023 | $3,755,700 | -4.2% | 135,000 | -10.0% | 0.41% | +0.7% |
Q4 2022 | $3,919,500 | +15.1% | 150,000 | 0.0% | 0.41% | +14.6% |
Q3 2022 | $3,405,000 | -23.8% | 150,000 | 0.0% | 0.36% | -29.7% |
Q2 2022 | $4,469,000 | -5.6% | 150,000 | -16.7% | 0.51% | +8.8% |
Q1 2022 | $4,736,000 | -3.4% | 180,000 | -14.3% | 0.47% | +43.3% |
Q4 2021 | $4,904,000 | -24.3% | 210,000 | 0.0% | 0.33% | -28.4% |
Q3 2021 | $6,476,000 | -14.6% | 210,000 | -32.1% | 0.46% | -11.7% |
Q2 2021 | $7,585,000 | +93.9% | 309,354 | +47.8% | 0.52% | +88.6% |
Q1 2021 | $3,911,000 | -6.4% | 209,354 | 0.0% | 0.27% | -19.9% |
Q4 2020 | $4,177,000 | -18.7% | 209,354 | -32.5% | 0.34% | -25.4% |
Q3 2020 | $5,137,000 | -14.6% | 310,000 | 0.0% | 0.46% | -29.7% |
Q2 2020 | $6,016,000 | +4.6% | 310,000 | -22.3% | 0.65% | -19.4% |
Q1 2020 | $5,754,000 | -23.8% | 399,000 | +7.8% | 0.81% | -2.5% |
Q4 2019 | $7,548,000 | +75.9% | 370,000 | +68.2% | 0.83% | +53.7% |
Q3 2019 | $4,292,000 | +58.1% | 220,000 | +82.7% | 0.54% | +79.9% |
Q2 2019 | $2,714,000 | -38.2% | 120,399 | 0.0% | 0.30% | -41.8% |
Q1 2019 | $4,393,000 | -14.6% | 120,399 | -31.0% | 0.51% | -12.6% |
Q4 2018 | $5,147,000 | -59.8% | 174,399 | -42.2% | 0.59% | -54.2% |
Q3 2018 | $12,800,000 | +7.2% | 301,610 | +4.0% | 1.28% | +5.0% |
Q2 2018 | $11,936,000 | +126.8% | 290,000 | +219.4% | 1.22% | +88.3% |
Q1 2018 | $5,263,000 | +63.5% | 90,800 | +54.4% | 0.65% | +49.2% |
Q4 2017 | $3,218,000 | -56.3% | 58,800 | -59.4% | 0.44% | -53.8% |
Q3 2017 | $7,372,000 | -6.1% | 145,000 | +7.1% | 0.94% | -16.5% |
Q2 2017 | $7,850,000 | -4.4% | 135,409 | -3.6% | 1.13% | -13.4% |
Q1 2017 | $8,214,000 | +95.5% | 140,409 | +85.7% | 1.30% | +61.4% |
Q4 2016 | $4,202,000 | -99.9% | 75,599 | -56.9% | 0.81% | -38.6% |
Q3 2016 | $8,258,421,000 | +140804.6% | 175,599 | +29.5% | 1.31% | +26.0% |
Q2 2016 | $5,861,000 | -57.7% | 135,599 | -66.5% | 1.04% | -62.1% |
Q1 2016 | $13,847,000 | +10.4% | 405,000 | +156.3% | 2.75% | +45.0% |
Q4 2015 | $12,542,000 | -16.2% | 158,000 | -38.0% | 1.90% | -20.5% |
Q3 2015 | $14,961,000 | -33.4% | 255,000 | -26.9% | 2.38% | -11.6% |
Q2 2015 | $22,455,000 | +42.8% | 349,000 | +35.3% | 2.70% | +1.7% |
Q1 2015 | $15,730,000 | +87.8% | 258,000 | +80.4% | 2.65% | +9.3% |
Q4 2014 | $8,374,000 | -26.6% | 143,000 | -46.2% | 2.43% | -27.3% |
Q3 2014 | $11,403,000 | +34.9% | 266,000 | +58.3% | 3.34% | +33.1% |
Q2 2014 | $8,455,000 | -4.7% | 168,000 | -16.5% | 2.51% | -5.8% |
Q1 2014 | $8,874,000 | +50.5% | 201,277 | +38.8% | 2.66% | +15.5% |
Q4 2013 | $5,896,000 | – | 145,000 | – | 2.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
13D Management LLC | 415,055 | $9,268,000 | 4.85% |
Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |